0001237899-17-000019.txt : 20170809 0001237899-17-000019.hdr.sgml : 20170809 20170809160352 ACCESSION NUMBER: 0001237899-17-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170807 FILED AS OF DATE: 20170809 DATE AS OF CHANGE: 20170809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Landry Robert E CENTRAL INDEX KEY: 0001585160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 171017850 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9143477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-08-07 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001585160 Landry Robert E 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Finance & CFO Common Stock 2017-08-07 4 M 0 2000 272.7 A 9099 D Common Stock 2017-08-07 4 F 0 1167 466.98 D 7932 D Common Stock 2017-08-07 4 F 0 307 466.98 D 7625 D Common Stock 2017-08-08 4 S 0 100 469.91 D 7525 D Common Stock 2017-08-08 4 S 0 100 471.0 D 7425 D Common Stock 2017-08-08 4 S 0 100 472.54 D 7325 D Common Stock 2017-08-08 4 S 0 226 473.57 D 7099 D Common Stock 83 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 272.7 2017-08-07 4 M 0 2000 0.0 D 2023-09-09 Common Stock 2000 64000 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 226 shares of Company stock on August 8, 2017 at prices ranging from $473.27 to $472.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2017 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Robert E. Landry 2017-08-09